level of 2m, g% ; since the former blood level requires 8-I Og. daily of sulphetrone and the latter 2g. daily, the matter is obviously of some importance both from a medical and economic point of view. 
CuI. 1.
Sulphunll. Method f01' Urine. A sa mple of urine from a patient undergoing therapy with a proprietary sulphone is a n a l ysed for its c oncentration of sulp h on e by the usual technique (see previous paper) . I n order to facilitate the p roc ed u re a urine of > roomg % sulphetrone is obtained and > 50mg % diasone is ohtained , and after an a l ysi s the urines are ad justed exactly to some convenient fi gure (e.g., roomg % and 50mg% ) by the addition of water. Control soluti on s of s ul phetrone and diasone are then prepared by weighing t h e pure powders and dissolving in a fresh urine obtained from a perso n not on sulphone or sulphonamide t herapy. 100mi. portions of both the control and the urine to be tested are then extracted with t hree aliq uots representing a total volume of Jooml. of ethyl a cetate . The extracts are then dried over a n hyd rous sod ium sulphate and rml. . Method for Blood. c.20ml. of blood from a patient are withdrawn.
DADPS
Tml. of this sample is estimated for the sulphone in question as desc ribed in Part I. Joml. of the remaining blood are mixed with soml. satd . MgS04 and then centrifuged until sep aration is obtai ned. roml . of the supernatent Jluid is then shaken with romls. of ethyl acetate.
rml. of the eth y l acetate extract is then estimated as for the extract obtained from u r i ne.
A "b lank " estimation is performed upon blood extracted from a person not undergoing sulphone therapy and to which blood hae been added a known equivalent quantity of t he s ulph one to be estimated .
Result. Using this technique n o diaminodip h eny lsulphone could b" discovered in the b lood of patients undergoing su l pbetrone ':berapy. \Vith diasone, equ ivocal results were obtained , due to some grossness of the tec:hnical procedure Further studies are contemplated : the above results and methods are reported in order that the work may be repeated in other research lahoratories
That diaminodiphenylsulphone may b e extracted from the urine of patients undergoing therapy with proprietary suI phones is evidence from the partial hydrolysis of these compounds in the body. The grossness of the methods used do not allow of any conclusions re g arding the p artiti o n o f the sulphones in the blood .
The presence of diaminodiphenylsulphone in the urine however is strong evidence for the presence of diaminodiphenylsulphone in the blood. The author holds the view that in the light of the evidence presented . both experimental and theoretical. the In 1)IVO partial hydrolysis of the proprietary sulphones must be accepted .
TOX IC EFFECTS OF TH E PROPRIETARY SULPHONES.
Since the sulphones are in some measure degraded to diamino diphenylsulphone the toxic effects of any proprietary drug may be due to a combination of two factors :
a. The toxic action of diaminodiphenylsulphone.
h. The toxic effect of the whole molecule of the sulphone or portion of the molecule remaining after liberation of diaminodiphenylsulphone.
In this article the toxic phenomena of three sulphones will be' studied in an <t.ttempt to discover whether diaminodiphenylsulphone possesses intrinsic toxic qualities which renders its use in leprosy therapy inadvisable.
BLOOD DYSCRASIAS.
AnaemIa.
That the administration of the sulphones whether orally ()r parentally results in an anaemia (Ref. 4) . is well known . That the anaemIa produced may differ quantitavely with (a) the type of sulphone and (b) the mode of administration is not generally realised.
Sulphetrone. The anaemia produced is in the majority of cases not severe on a dosage of not more than 5.o. g. daily when the exhibItIon of the dmg IS gradual. A fall of > 3g. Hb% in the first six weeks is usual. and if iron is given concurrently with the sulphe trone the body stabilises itself within a matter of two or three months. The anaemi:t is hypochromic in type. no evidence for a marked haemolytic process has been found from studies of plasma bilirubin. red cell fragility. urobilinogen excretion or the presence of methaemalbuminaemia.
If the exhibition of the drug is rapid the[f� occurs in Southern Nigeria a syndrome of glandular enlargement. splenomegaly. pyrexia and disturbance of liver function exhibition tb� blood picture similar to that of infectious mononucleosis. This effect is seen with all the sulphones when the exhibition of the drug is rapid. So far as is known it occurs only in this area-no such similar syndrome has been reported elsewhere. This particular action of the sulphones will be made the subject of a separate Both these factors may be responsible for the anaemia producing effect of sulphetrone administered orally .
In an effort to study the degree of responsibility of both the diaminodiphenylsulphone part of the sulphetrone molecule and the remaining cinnamyl-like portion for the anaemia produced by sulphetrone the following experiment was performed .
In Fig. 2 It is realised that this study is by no means as satisfactory as desired .
Diasone. When diasone is given orally in doses of 1.8g. daily an anaemia rather greater than that produced by Sg. of sulphetrone daily is produced . When the dose is raised above 2.og . daily then a definite haemolytic anaemia is detectable by means of raised urobilinogen, excretion, raised icterus index, and the occasional presence of methaemalbumen in the blood plasma.
The fall in the red cell count with oral diasone is of a much greater degree than with sulphetrone . Red cell count decreases of the order of 1.S to 2.0 million are not uncommon when the daily dose is 1.8g. General Comment. The' study of anaemia in Southern Nigeria is made difficult by the I1l.any intercurrent haemolytic infections to which the patients are exposed . There is also the unknown effect of the various de, grecs of liver dysfunction presf'nt in a large percentage of primitive African people in this area. Thus the effect of any drug upon the body may not be a pure cause and effect relationship. The anaemia produced by the sulphones is always more severe and treatment more difficult in patients with liver dysfunction.
Diaminodiphenylsulphone cannot be shewn however to be more anaemia·producing in these cases than diasone or sulphetrone.
